EnteraBio
在场
EnteraBio 的所有者是 Elbit Systems.
Elbit Systems 是一家在股票代码 ESLT (IL) 下上市的公司。
Elbit Systems 在 2 个国家有直接业务。Elbit Systems 拥有 3家子公司，其中包括 Cyberbit、Elbit Systems of America 和 EnteraBio。
他们在：
高管
生物技术
Elbit Systems 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
EnteraBio 的最新新闻稿
- Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils Vision as Premier Oral Peptide Company with Five Potential Programs in Development | Entera Bio Ltd.
- Entera Bio Reports Rapid Pharmacodynamic (PD) Response and Consistent Pharmacokinetic (PK) Data for its First-in-Class Oral PTH(1-34) Mini Tablets at the ASBMR 2023 Annual Meeting | Entera Bio Ltd.
- Entera Bio to Participate in Upcoming Investor Conferences | Entera Bio Ltd.
- Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes | Entera Bio Ltd.
- Entera Bio Announces Q2 2023 Financial Results and Corporate Updates | Entera Bio Ltd.
- Press Releases | Entera Bio Ltd.
- Entera Bio to Present Two Abstracts on its First-in-Class, Once Daily Oral hPTH(1-34) Peptide Tablets (EB613) for the Treatment of Post-Menopausal Women at High Risk of Fracture at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting
- Press Releases | Entera Bio Ltd.
- אחסון וורדפרס מנוהל - uPress
- Entera Bio Adds Sanofi Commercial Leader, Haya Taitel to its Board of Directors | Entera Bio Ltd.
- View more press releases Close
关于 EnteraBio 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Hillel Galitzer 
